138 related articles for article (PubMed ID: 26832790)
1. Targeting the Nuclear Import Receptor Kpnβ1 as an Anticancer Therapeutic.
van der Watt PJ; Chi A; Stelma T; Stowell C; Strydom E; Carden S; Angus L; Hadley K; Lang D; Wei W; Birrer MJ; Trent JO; Leaner VD
Mol Cancer Ther; 2016 Apr; 15(4):560-73. PubMed ID: 26832790
[TBL] [Abstract][Full Text] [Related]
2. Novel small molecule inhibitor of Kpnβ1 induces cell cycle arrest and apoptosis in cancer cells.
Ajayi-Smith A; van der Watt P; Mkwanazi N; Carden S; Trent JO; Leaner VD
Exp Cell Res; 2021 Jul; 404(2):112637. PubMed ID: 34019908
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Kpnβ1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer.
Chi RA; van der Watt P; Wei W; Birrer MJ; Leaner VD
BMC Cancer; 2021 Feb; 21(1):106. PubMed ID: 33530952
[TBL] [Abstract][Full Text] [Related]
4. A tight balance of Karyopherin β1 expression is required in cervical cancer cells.
Carden S; van der Watt P; Chi A; Ajayi-Smith A; Hadley K; Leaner VD
BMC Cancer; 2018 Nov; 18(1):1123. PubMed ID: 30445944
[TBL] [Abstract][Full Text] [Related]
5. The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation.
van der Watt PJ; Maske CP; Hendricks DT; Parker MI; Denny L; Govender D; Birrer MJ; Leaner VD
Int J Cancer; 2009 Apr; 124(8):1829-40. PubMed ID: 19117056
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the nuclear transporter, Kpnβ1, results in prolonged mitotic arrest and activation of the intrinsic apoptotic pathway in cervical cancer cells.
Angus L; van der Watt PJ; Leaner VD
Carcinogenesis; 2014 May; 35(5):1121-31. PubMed ID: 24398670
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of KPNβ1 in gastric cancer cell promotes tumor cell proliferation and predicts poor prognosis.
Zhu J; Wang Y; Huang H; Yang Q; Cai J; Wang Q; Gu X; Xu P; Zhang S; Li M; Ding H; Yang L
Tumour Biol; 2016 Jan; 37(1):661-72. PubMed ID: 26242264
[TBL] [Abstract][Full Text] [Related]
8. The nuclear import receptor Kpnβ1 and its potential as an anticancer therapeutic target.
van der Watt PJ; Stowell CL; Leaner VD
Crit Rev Eukaryot Gene Expr; 2013; 23(1):1-10. PubMed ID: 23557333
[TBL] [Abstract][Full Text] [Related]
9. Suppression of the nuclear transporter-KPNβ1 expression inhibits tumor proliferation in hepatocellular carcinoma.
Yang L; Hu B; Zhang Y; Qiang S; Cai J; Huang W; Gong C; Zhang T; Zhang S; Xu P; Wu X; Liu J
Med Oncol; 2015 Apr; 32(4):128. PubMed ID: 25794490
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Kpnβ1 and Kpnα2 importin proteins in cancer derives from deregulated E2F activity.
van der Watt PJ; Ngarande E; Leaner VD
PLoS One; 2011; 6(11):e27723. PubMed ID: 22125623
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of nuclear transporter, Kpnβ1, contributes to accelerated cell proliferation- and cell adhesion-mediated drug resistance (CAM-DR) in diffuse large B-cell lymphoma.
He S; Miao X; Wu Y; Zhu X; Miao X; Yin H; He Y; Li C; Liu Y; Lu X; Chen Y; Wang Y; Xu X
J Cancer Res Clin Oncol; 2016 Mar; 142(3):561-72. PubMed ID: 26498772
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Kpnβ1 expression inhibits human breast cancer cell proliferation by abrogating nuclear transport of Her2.
Sheng C; Qiu J; He Z; Wang H; Wang Q; Guo Z; Zhu L; Ni Q
Oncol Rep; 2018 Feb; 39(2):554-564. PubMed ID: 29251332
[TBL] [Abstract][Full Text] [Related]
13. KPNB1-mediated nuclear import is required for motility and inflammatory transcription factor activity in cervical cancer cells.
Stelma T; Leaner VD
Oncotarget; 2017 May; 8(20):32833-32847. PubMed ID: 28427184
[TBL] [Abstract][Full Text] [Related]
14. High Kpnβ1 expression promotes non-small cell lung cancer proliferation and chemoresistance via the PI3-kinase/AKT pathway.
Wang H; Wang D; Li C; Zhang X; Zhou X; Huang J
Tissue Cell; 2018 Apr; 51():39-48. PubMed ID: 29622086
[TBL] [Abstract][Full Text] [Related]
15. Nuclear import of exogenous FGF1 requires the ER-protein LRRC59 and the importins Kpnα1 and Kpnβ1.
Zhen Y; Sørensen V; Skjerpen CS; Haugsten EM; Jin Y; Wälchli S; Olsnes S; Wiedlocha A
Traffic; 2012 May; 13(5):650-64. PubMed ID: 22321063
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Importin β1 With a 2-Aminothiazole Derivative Resulted in G
Ha S; Choi J; Min NY; Lee KH; Ham SW
Anticancer Res; 2017 May; 37(5):2373-2379. PubMed ID: 28476803
[TBL] [Abstract][Full Text] [Related]
17. A mass spectrometry-based approach for the identification of Kpnβ1 binding partners in cancer cells.
Okpara MO; Hermann C; van der Watt PJ; Garnett S; Blackburn JM; Leaner VD
Sci Rep; 2022 Nov; 12(1):20171. PubMed ID: 36418423
[TBL] [Abstract][Full Text] [Related]
18. Functional genetic screens identify genes essential for tumor cell survival in head and neck and lung cancer.
Martens-de Kemp SR; Nagel R; Stigter-van Walsum M; van der Meulen IH; van Beusechem VW; Braakhuis BJ; Brakenhoff RH
Clin Cancer Res; 2013 Apr; 19(8):1994-2003. PubMed ID: 23444224
[TBL] [Abstract][Full Text] [Related]
19. Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.
Qin JJ; Wang W; Voruganti S; Wang H; Zhang WD; Zhang R
Oncotarget; 2015 Feb; 6(5):2623-40. PubMed ID: 25739118
[TBL] [Abstract][Full Text] [Related]
20. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
